Find Sivelestat Sodium Hydrate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Sivelestat sodium tetrahydrate, 201677-61-4, Sivelestat sodium hydrate, Elaspol, Ono-5046.na, Ly544349 sodium hydrate
Molecular Formula
C20H29N2NaO11S
Molecular Weight
528.5  g/mol
InChI Key
PLHREJBSQUSUCW-UHFFFAOYSA-M
FDA UNII
737RR8Y409

Sivelestat Sodium Hydrate
1 2D Structure

Sivelestat Sodium Hydrate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
sodium;2-[[2-[[4-(2,2-dimethylpropanoyloxy)phenyl]sulfonylamino]benzoyl]amino]acetate;tetrahydrate
2.1.2 InChI
InChI=1S/C20H22N2O7S.Na.4H2O/c1-20(2,3)19(26)29-13-8-10-14(11-9-13)30(27,28)22-16-7-5-4-6-15(16)18(25)21-12-17(23)24;;;;;/h4-11,22H,12H2,1-3H3,(H,21,25)(H,23,24);;4*1H2/q;+1;;;;/p-1
2.1.3 InChI Key
PLHREJBSQUSUCW-UHFFFAOYSA-M
2.1.4 Canonical SMILES
CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=C2C(=O)NCC(=O)[O-].O.O.O.O.[Na+]
2.2 Other Identifiers
2.2.1 UNII
737RR8Y409
2.3 Synonyms
2.3.1 MeSH Synonyms

1. N-(2-(4-(2,2-dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic Acid

2. Ono 5046

3. Ono-5046

4. Ono-ei-600

5. Sivelestat

2.3.2 Depositor-Supplied Synonyms

1. Sivelestat Sodium Tetrahydrate

2. 201677-61-4

3. Sivelestat Sodium Hydrate

4. Elaspol

5. Ono-5046.na

6. Ly544349 Sodium Hydrate

7. Sivelestat (sodium Tetrahydrate)

8. Sivelestat Sodium [usan]

9. Ei-546

10. Ono 5046

11. Sivelestat Sodium (usan)

12. Ono-5046 Sodium Hydrate

13. Sivelestat Sodium Salt Tetrahydrate

14. Ly-544349 Sodium Hydrate

15. 737rr8y409

16. Sodium;2-[[2-[[4-(2,2-dimethylpropanoyloxy)phenyl]sulfonylamino]benzoyl]amino]acetate;tetrahydrate

17. Dsstox_cid_26727

18. Dsstox_rid_81857

19. Dsstox_gsid_46727

20. Glycine, N-(2-(((4-(2,2-dimethyl-1-oxopropoxy)phenyl)sulfonyl)amino)benzoyl)-, Monosodium Salt, Tetrahydrate

21. Sodium ((2-(((4-((2,2-dimethylpropanoyl)oxy)phenyl)sulfonyl)amino)benzoyl)amino)acetate Tetrahydrate

22. Ono5046-na;sodium Sivelestat;ei546 Sodium;ly544349 Sodium

23. Sodium Sivelestat

24. Sodium 2-(2-(4-(pivaloyloxy)phenylsulfonamido)benzamido)acetate Tetrahydrate

25. Ei546 Sodium Tetrahydrate;ly544349 Sodium Tetrahydrate;ono5046 Sodium Tetrahydrate

26. Sodium,2-[[2-[[4-(2,2-dimethylpropanoyloxy)phenyl]sulfonylamino]benzoyl]amino]acetate,tetrahydrate

27. Elaspol (tn)

28. Ei546 Sodium

29. Cas-201677-61-4

30. Ly544349 Sodium

31. Ncgc00167577-01

32. Ono5046-na

33. Unii-737rr8y409

34. Sivelestatsodiumhydrate

35. Elaspol Sodium Salt Tetrahydrate

36. Chembl3182314

37. Dtxsid0046727

38. Chebi:32133

39. Sivelestat (sodium Salt Hydrate)

40. Sivelestat Sodium [mart.]

41. Sivelestat Sodium Hydrate (jp17)

42. Sivelestat Sodium [who-dd]

43. Act02667

44. Bcp09535

45. Tox21_112570

46. Hy-17443b

47. S4666

48. Akos015901086

49. Akos015963357

50. Tox21_112570_1

51. Ac-1291

52. Ccg-269903

53. Cs-3380

54. Sivelestat Sodium Hydrate [jan]

55. Sivelestat Sodium For Injection (jp17)

56. Ncgc00263570-01

57. Ft-0748809

58. D01918

59. Sivelestat Sodium Salt Tetrahydrate [mi]

60. A909240

61. J-013081

62. Q27266149

63. Sodium ((2-(((4-((2,2-dimethylpropanoyl)oxy)phenyl)sulfonyl)amino)benzoyl)amino)acetate Tetrahydrate

2.4 Create Date
2008-02-05
3 Chemical and Physical Properties
Molecular Weight 528.5 g/mol
Molecular Formula C20H29N2NaO11S
Hydrogen Bond Donor Count6
Hydrogen Bond Acceptor Count12
Rotatable Bond Count9
Exact Mass528.13897520 g/mol
Monoisotopic Mass528.13897520 g/mol
Topological Polar Surface Area154 Ų
Heavy Atom Count35
Formal Charge0
Complexity738
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count6
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Serine Proteinase Inhibitors

Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. (See all compounds classified as Serine Proteinase Inhibitors.)


API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

read-more
read-moreread-more

01

IFSCC
Not Confirmed
arrow
arrow
IFSCC
Not Confirmed

Sivelestat sodium hydrate

Registration Number : 225MF10154

Registrant's Address : Via San Faustino, 68 20134 MILANO-Italy

Initial Date of Registration : 2013-08-09

Latest Date of Registration : 2013-08-09

blank

02

IFSCC
Not Confirmed
arrow
arrow
IFSCC
Not Confirmed

Japanese Pharmacopoeia Sivelestat Sodium Hydrate For manufacturing purposes only

Registration Number : 226MF10229

Registrant's Address : 1-1-2 Nishinomiyahama, Nishinomiya City, Hyogo Prefecture

Initial Date of Registration : 2014-12-08

Latest Date of Registration : 2014-12-08

blank

03

IFSCC
Not Confirmed
arrow
arrow
IFSCC
Not Confirmed

Sivelestat sodium hydrate

Registration Number : 225MF10161

Registrant's Address : Via Matteotti 249,28062 CAMERI (NOVARA)/ITALY

Initial Date of Registration : 2013-08-14

Latest Date of Registration : 2013-08-14

blank

04

IFSCC
Not Confirmed
arrow
arrow
IFSCC
Not Confirmed

Sivelestat sodium hydrate "SFL"

Registration Number : 218MF10428

Registrant's Address : Osaka Prefecture, Osaka City, Chuo Ward, Doshomachi 3-1-6

Initial Date of Registration : 2006-04-27

Latest Date of Registration : 2014-05-29

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

Biotech Week Boston
Not Confirmed
arrow
arrow
Biotech Week Boston
Not Confirmed

Sivelestat Sodium Hydrate

About the Company : Beijing Fukangren Biopharmaceutical Technology Co., Ltd. started its drug R&D service in 1999 and is the CRO company with the longest continuous service time in China. Fukangren no...

Beijing Fukangren Biopharmaceutical Technology Co., Ltd. started its drug R&D service in 1999 and is the CRO company with the longest continuous service time in China. Fukangren now has 3 pharmaceutical R&D centers, 1 clinical R&D center, 4 API production bases and 1 preparation production base, forming an end-to-end CDMO service system that can provide customers with drug R&D and production. The development of high-end formulations is a major advantage of Fukangren. Among them, multiple platform projects such as sustained and controlled release formulations.
blank

02

Biotech Week Boston
Not Confirmed
arrow
arrow
Biotech Week Boston
Not Confirmed

Sivelestat Sodium Hydrate

About the Company : Guangzhou Green Cross Pharmaceutical is a leading Chinese manufacturer of amino acid injection formulations and a full-service provider of high-end parenteral nutrition and generic...

Guangzhou Green Cross Pharmaceutical is a leading Chinese manufacturer of amino acid injection formulations and a full-service provider of high-end parenteral nutrition and generic drugs. Among the first GMP-certified pharmaceutical companies in China, we have grown into a comprehensive group with integrated R&D, production, and sales. Our operations include one R&D center and five manufacturing bases for APIs and formulations.
blank

03

Biotech Week Boston
Not Confirmed
arrow
arrow
Biotech Week Boston
Not Confirmed

Sivelestat Sodium Hydrate

About the Company : Alchemia is dedicated to the production of high-quality active ingredients and intermediates for the pharmaceutical industry. Our goal is to offer products manufactured to the hig...

Alchemia is dedicated to the production of high-quality active ingredients and intermediates for the pharmaceutical industry. Our goal is to offer products manufactured to the highest standards of excellence in accordance with the following business philosophy: • State-of-the-art manufacturing facilities • Process optimization and continued improvement • Ongoing education and training of personnel • Long-term partnerships with suppliers and customers built on transparency • A constant exchange of ideas with the academic community.
blank

04

Procos

Italy
Biotech Week Boston
Not Confirmed
arrow

Procos

Italy
arrow
Biotech Week Boston
Not Confirmed

Sivelestat Sodium Hydrate

About the Company : Procos S.p.A. is a wholly owned subsidiary of the Japanese company, CBC Co. Ltd Group, specializing in the development, scale-up and production of Active Pharmaceutical Ingredients...

Procos S.p.A. is a wholly owned subsidiary of the Japanese company, CBC Co. Ltd Group, specializing in the development, scale-up and production of Active Pharmaceutical Ingredients (APIs), advanced intermediates and related services for the pharmaceutical industry. Our core business sectors include custom synthesis and Generic API manufacturing. The manufacturing site is located in Cameri, Italy. This 110,000 sq. meter, cutting-edge multipurpose plant, fully designed under cGMP compliance, has been successfully audited and approved by the main regulatory authorities including AIFA, FDA and PMDA.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Global Sales Information

Do you need Business Intel? Ask us

Annual Reports

read-more
read-more

01

Brand Name : Elaspol

Sivelestat

arrow
Cell Therapy
Not Confirmed

Brand Name : Elaspol

Japan
arrow
Cell Therapy
Not Confirmed

Sivelestat

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2017 Revenue in Millions : 0

2016 Revenue in Millions : 3

Growth (%) : -100

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 201677-61-4 / Sivelestat Sodium Hydrate API manufacturers, exporters & distributors?

Sivelestat Sodium Hydrate manufacturers, exporters & distributors 1

61

PharmaCompass offers a list of Sivelestat Sodium Hydrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sivelestat Sodium Hydrate manufacturer or Sivelestat Sodium Hydrate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sivelestat Sodium Hydrate manufacturer or Sivelestat Sodium Hydrate supplier.

PharmaCompass also assists you with knowing the Sivelestat Sodium Hydrate API Price utilized in the formulation of products. Sivelestat Sodium Hydrate API Price is not always fixed or binding as the Sivelestat Sodium Hydrate Price is obtained through a variety of data sources. The Sivelestat Sodium Hydrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Sivelestat Sodium Hydrate

Synonyms

Sivelestat sodium tetrahydrate, 201677-61-4, Elaspol, Ono-5046.na, Ly544349 sodium hydrate, Sivelestat (sodium tetrahydrate)

Cas Number

201677-61-4

Unique Ingredient Identifier (UNII)

737RR8Y409

Sivelestat Sodium Hydrate Manufacturers

A Sivelestat Sodium Hydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sivelestat Sodium Hydrate, including repackagers and relabelers. The FDA regulates Sivelestat Sodium Hydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sivelestat Sodium Hydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Sivelestat Sodium Hydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Sivelestat Sodium Hydrate Suppliers

A Sivelestat Sodium Hydrate supplier is an individual or a company that provides Sivelestat Sodium Hydrate active pharmaceutical ingredient (API) or Sivelestat Sodium Hydrate finished formulations upon request. The Sivelestat Sodium Hydrate suppliers may include Sivelestat Sodium Hydrate API manufacturers, exporters, distributors and traders.

click here to find a list of Sivelestat Sodium Hydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Sivelestat Sodium Hydrate USDMF

A Sivelestat Sodium Hydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Sivelestat Sodium Hydrate active pharmaceutical ingredient (API) in detail. Different forms of Sivelestat Sodium Hydrate DMFs exist exist since differing nations have different regulations, such as Sivelestat Sodium Hydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Sivelestat Sodium Hydrate DMF submitted to regulatory agencies in the US is known as a USDMF. Sivelestat Sodium Hydrate USDMF includes data on Sivelestat Sodium Hydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sivelestat Sodium Hydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Sivelestat Sodium Hydrate suppliers with USDMF on PharmaCompass.

Sivelestat Sodium Hydrate JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Sivelestat Sodium Hydrate Drug Master File in Japan (Sivelestat Sodium Hydrate JDMF) empowers Sivelestat Sodium Hydrate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Sivelestat Sodium Hydrate JDMF during the approval evaluation for pharmaceutical products. At the time of Sivelestat Sodium Hydrate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Sivelestat Sodium Hydrate suppliers with JDMF on PharmaCompass.

Sivelestat Sodium Hydrate GMP

Sivelestat Sodium Hydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Sivelestat Sodium Hydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sivelestat Sodium Hydrate GMP manufacturer or Sivelestat Sodium Hydrate GMP API supplier for your needs.

Sivelestat Sodium Hydrate CoA

A Sivelestat Sodium Hydrate CoA (Certificate of Analysis) is a formal document that attests to Sivelestat Sodium Hydrate's compliance with Sivelestat Sodium Hydrate specifications and serves as a tool for batch-level quality control.

Sivelestat Sodium Hydrate CoA mostly includes findings from lab analyses of a specific batch. For each Sivelestat Sodium Hydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Sivelestat Sodium Hydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sivelestat Sodium Hydrate EP), Sivelestat Sodium Hydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sivelestat Sodium Hydrate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty